Roxane Settles Price Inflation Suit For $1.8M
Generic-drug maker Boehringer Ingelheim Roxane Inc. has agreed to pay Massachusetts' state Medicaid program $1.8 million to settle a lawsuit alleging that it defrauded the program by overstating the cost of...To view the full article, register now.
Already a subscriber? Click here to view full article